Cell Source Operating Cash Flow Growth & History (CLCS)

Cell Source's operating cash flow was −$2.7M for fiscal 2024.

View full Cell Source company overview

Cell Source annual operating cash flow history

Cell Source annual operating cash flow

Fiscal yearPeriod endedOperating cash flowChangeGrowth
20242024-12-31−$2.7M−$336,271
20232023-12-31−$2.3M$790,795
20222022-12-31−$3.1M$239,996
20212021-12-31−$3.4M−$604,051
20202020-12-31−$2.8M−$187,419
20192019-12-31−$2.6M−$585,098
20182018-12-31−$2.0M$285,700
20172017-12-31−$2.3M−$793,754
20162016-12-31−$1.5M$506,550
20152015-12-31−$2.0M$1.1M
20142014-12-31−$3.1M−$4.0M
20132013-12-31$894,000

Cell Source operating cash flow trends

Over the last five fiscal years, Cell Source's operating cash flow decreased from −$2.6M to −$2.7M, a change of −$96,950. The latest reported quarter, Q1 2025, shows −$600,391.

About the metric

What operating cash flow means

Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.

Calculation and source

SEC-reported operating cash flow

TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cell Source source filings ↗

Community posts

It’s quiet here.

No posts about CLCS yet. Start the conversation.

Write the first post